Marieluise Kirchner

19PUBLICATIONS
165CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsGenome structure and regulationProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Nov 19, 2024
Proteomic insights into circadian transcription regulation: novel E-box interactors revealed by proximity labeling.

Manon Torres, Marieluise Kirchner, Caroline G Marks

|Oct 01, 2024
Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network.

Bertram Klinger, Isabel Rausch, Anja Sieber

Pageof 4